Trial intelligence / Profile preview

Tewlip: Fish Oil IVFE on Skin Barrier in Parenteral Nutrition

NCT02550860Phase 3Terminated

Sponsor
Hospices Civils de Lyon
Start
Jan 2015
Primary completion
Sep 2017
Modality
Nanoparticles
Countries
1
01

Overview

A Phase 3 trial of Lipidem in Intestinal disease, sponsored by Hospices Civils de Lyon. Started Jan 2015; status: terminated.

02

Drugs

Lipidem
03

Conditions

Intestinal disease

Beyond the preview

Go deeper on NCT02550860.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02550860.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call